Skip to main content
. 2023 Apr 3;21:67. doi: 10.1186/s12964-023-01094-4

Table 2.

Therapeutic approaches to regulate JAK2/STAT3 in OA

Classification Name Effect on JAK2/STAT3 Mechanism Consequence References
MicroRNAs MiR-375 inhibition activation ADAMTS-5↓, MMP-13↓, COL-II↑, AGG↑, p-JAK2/JAK2↑, p-STAT3/STAT3↑, Bcl-2/Bax↑ Improved the ability of chondrocytes to antagonize oxidative stress and maintain ECM homeostasis [28, 67]
MiR-149-5p Inhibition AGT↓, ANGII, AT1R Regulated and combined AGT, promoted the inflammatory responses induced by IL-6 [39]
MiR-216a-5p Inhibition Bax↓, Caspase-3↓, Bcl-2↑ Promoted the proliferation and migrations well as inhibited apoptosis in chondrocytes [29]
MiR-224-5p Inhibition MMP-9↓, MMP-13↓, COL-II↑, AGG↑, Caspase-3↓, Circ_PDE1C↓ Inhibited chondrocytes apoptosis and ECM degradation. Targeted CCL2 and accelerated cartilage degradation [44]
Traditional Chinese medicine Danshen activation P-JAK2, p-STAT3↓, GSH, SOD, CAT↑, Bcl-2↑, Bax, caspase3, PARP↓ Attenuated cartilage injuries by activating JAK2/STAT3 pathway [71]
Diosgenin activation P-JAK2, p-STAT3, SDH, COX, SOD↑, Bax↓ Protected OA cartilage cells by activating the JAK2/STAT3 pathway, which effectively reduces mitochondrial oxidative stress damage and apoptosis in OA cells during the pathological process [73]
curcumin activation P-JAK2, p-STAT3, Increased the mitochondrial resistance to oxidative stress in chondrocytes, significantly slows down the degeneration of articular cartilage, and reduces the level of OA progression [75]
Resveratrol Inhibition JAK2, STAT3, SOCS3, MMP-13↓ No significant leptin resistance existed in articular cartilage of obesity-related OA and the inhibitory effect of RES on obesity-related OA via alleviating JAK2/STAT3 signaling pathway [77]
Inhibitors AG490 Inhibition JAK2↓ Inhibited JAK2/STAT3 activation and apoptosis in chondrocytes induced by IL-1β [62, 79]
WP1066 Inhibition JAK2, STAT3↓ Downregulated the expression of JAK2/STAT3 to suppress the chondrocytic inflammation responses induced by IL-6 [39]
Tofacitinibis Inhibition JAK, STAT3↓ Moderated chondrogenic hypertrophy in human chondrocyte lines via downregulation of JAK/STAT3 [68]
Pranlukast Inhibition JAK2, STAT1↓ Reversed the enhancement levels of pro-inflammatory cytokines to prevent the progression of OA [81]
STA21 Inhibition STAT3↓ Blocked STAT3 dimerization and DNA binding to alleviate joint pain and cartilage damage [82]
Stattic Inhibition STAT3↓ Reduced the severity of OA cartilage lesions and decreased the size of osteophytes. Stattic had no significant effect on the synovium or the subchondral bone [55]